
US-based Theracos, Inc. is a pharmaceutical R&D firm, developing novel therapies for unmet medical needs since 2000.
Theracos, Inc., founded in 2000 and based in Marlborough, Massachusetts, is a privately held pharmaceutical research and development company. Its core mission is to develop novel therapeutic agents for diseases with significant unmet medical needs. The company focuses on creating affordable drugs for important diseases, aiming to provide access to new medications for patients with common conditions. Theracos is actively conducting multiple programs in human clinical testing, leveraging its deep understanding of the marketplace and extensive network of partners.
Notable affiliated individuals and investors in Theracos include experts in pharmaceutical R&D and healthcare investment. The company has achieved significant milestones in drug development, including advancing several therapeutic agents into clinical trials. Theracos' impact is marked by its commitment to making innovative treatments accessible and affordable, potentially transforming the landscape of medical care for patients with common yet underserved diseases.

Therio

Thar Pharmaceuticals
tharpharma.com

Therabron Therapeutics
therabron.com

Thetis Pharmaceuticals
thetispharma.com

Applied Therapeutics

Thesan Pharmaceuticals
thesanpharma.com

NeuroTherapeutics Pharma

PleoPharma
pleopharma.com

TheraVasc
Tisento Therapeutics

Theron Pharmaceuticals

Therapyx
therapyxinc.com

Theradaptive
theradaptive.com

Scienture
scienture.com

Cyclo Therapeutics
Companies similar to Theracos include Therio, Thar Pharmaceuticals, Therabron Therapeutics and Thetis Pharmaceuticals.
Theracos was founded in 2000.
Theracos' headquarters is located in Marlborough, MA, US.
Theracos' most recent funding round was for $25M (USD) in January 2016.
As of Jan 15, 2016, Theracos has raised a total of $118.1M (USD).
Theracos has 75 employees as of Feb 5, 2024.